Dr Howard Hodis
Professor of Medicine and Preventive Medicine and Director of the Atherosclerosis Research Unit, Keck School of Medicine at the University of Southern California in Los Angeles.
Dr Hodis addresses gender differences and primary prevention for cardiovascular disease in midlife women. He also explains the new class of LDL-lowering drugs available and how they differ from statins.
Content updated May 2018